Rockefeller Capital Management Portfolio holdings
AUM
$45.6B
1-Year Return
21.96%
This Quarter Return
+7.55%
1 Year Return
+21.96%
3 Year Return
+89.19%
5 Year Return
+147.02%
10 Year Return
–
AUM
$17.8B
AUM Growth
+$2.97B
(+20%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
11.04%
Top 10 Holdings %
Top 10 Hldgs %
20.72%
Holding
3,762
New
434
Increased
1,758
Reduced
755
Closed
213
Top Buys
| 1 |
Coherent
COHR
|
$68.4M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
$64.5M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
$56.1M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$42.4M |
| 5 |
Apple
AAPL
|
$40.3M |
Top Sells
| 1 |
Aflac
AFL
|
$120M |
| 2 |
Microsoft
MSFT
|
$81.8M |
| 3 |
CERN
Cerner Corp
CERN
|
$81.1M |
| 4 |
Agnico Eagle Mines
AEM
|
$54.5M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$48.4M |
Sector Composition
| 1 | Technology | 20.16% |
| 2 | Financials | 14.32% |
| 3 | Healthcare | 12.64% |
| 4 | Consumer Discretionary | 8.27% |
| 5 | Industrials | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Chevron
CVX
$318B
| $68.1M | 0.38% |
649,988
+48,484
| +8% | +$5.08M |
|
52
BioMarin Pharmaceuticals
BMRN
$10.9B
| $67.9M | 0.38% |
813,453
+53,161
| +7% | +$4.44M |
|
53
Alnylam Pharmaceuticals
ALNY
$59.4B
| $67.4M | 0.38% |
397,309
-3,251
| -0.8% | -$551K |
|
54
Verizon
VZ
$186B
| $67.3M | 0.38% |
1,200,482
-1,933
| -0.2% | -$108K |
|
55
PepsiCo
PEP
$201B
| $65.7M | 0.37% |
443,436
+12,061
| +3% | +$1.79M |
|
56
ResMed
RMD
$40.1B
| $65.5M | 0.37% |
265,561
-6,214
| -2% | -$1.53M |
|
57
Honeywell
HON
$137B
| $63.8M | 0.36% |
290,769
+36,719
| +14% | +$8.05M |
|
58
McDonald's
MCD
$226B
| $63.6M | 0.36% |
275,126
+56,166
| +26% | +$13M |
|
59
Oracle
ORCL
$626B
| $63.1M | 0.36% |
810,888
+97,407
| +14% | +$7.58M |
|
60
iShares Core S&P 500 ETF
IVV
$666B
| $61.5M | 0.35% |
143,039
-2,139
| -1% | -$920K |
|
61
Nike
NKE
$111B
| $61.4M | 0.35% |
397,181
+9,601
| +2% | +$1.48M |
|
62
Thermo Fisher Scientific
TMO
$185B
| $60.6M | 0.34% |
120,216
+24,682
| +26% | +$12.5M |
|
63
Neurocrine Biosciences
NBIX
$13.9B
| $60.4M | 0.34% |
620,721
-2,176
| -0.3% | -$212K |
|
64
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $59.6M | 0.34% |
1,157,213
-31,607
| -3% | -$1.63M |
|
65
Salesforce
CRM
$233B
| $58.9M | 0.33% |
241,099
+47,083
| +24% | +$11.5M |
|
66
SPDR Gold Trust
GLD
$110B
| $58.6M | 0.33% |
353,836
+127,888
| +57% | +$21.2M |
|
|
67
Agnico Eagle Mines
AEM
$74.5B
| $58M | 0.33% |
960,309
-900,925
| -48% | -$54.5M |
|
68
Vanguard Information Technology ETF
VGT
$99.7B
| $57.4M | 0.32% |
144,029
+7,145
| +5% | +$2.85M |
|
69
Adobe
ADBE
$146B
| $56.5M | 0.32% |
96,439
+13,494
| +16% | +$7.9M |
|
70
Bristol-Myers Squibb
BMY
$95B
| $56M | 0.32% |
837,352
+234,152
| +39% | +$15.6M |
|
71
Danaher
DHR
$143B
| $55.8M | 0.31% |
234,365
+21,950
| +10% | +$5.22M |
|
72
TSMC
TSM
$1.22T
| $55.7M | 0.31% |
463,854
+46,221
| +11% | +$5.55M |
|
73
Mastercard
MA
$538B
| $55.3M | 0.31% |
151,389
+2,411
| +2% | +$880K |
|
74
Vanguard Total World Stock ETF
VT
$51.8B
| $54.5M | 0.31% |
525,882
+114,709
| +28% | +$11.9M |
|
75
Merck
MRK
$210B
| $53.5M | 0.3% |
688,091
-71,346
| -9% | -$5.55M |
|